US Transparency Reporting

Vector Health re-engineered the Global Transparency solution on a new platform 2020, giving our customers an extraordinary advantage. Small to Medium sized drug and device manufacturers are calling the “new” solution “innovative,” “powerful,” “customer-friendly,” and “cost competitive.”

US Federal & State Aggregate Spend reporting tool

Discover our Intelligent compliance platform.

EZloader tool to upload data from any source in any format

End to End visibility for your stakeholders throughout the journey


450+ built-in QA/QC checks on your data

Your Data Your Way

Our advanced Federal and State reporting tool helps you submit reports in time.

  • Send or Load data in any format (Spreadsheets, Images, gif, etc.)
  • Identify and alert for high risk transactions
  • No reporting templates
  • Automated Data Cleansing, Cleaning, and Mapping

Accurate Physician Matching

Organize and validate your data with VectorHealth’s HCP Master

  • Data cleansing for accuracy
  • Verify HCPs/HCPs for precise profiling
  • Integrated NPPES, VPL & NPI data sources
  • Manual verification of HCPs/HCOs

Best in class spend analytics and monitoring

Tracks the spend data from inception to completion.

    • Visuals for Stakeholder briefings
    • Interactive and actionable analytics
    • Benchmark spends through several measures including spend history, HCP history, competitor spend, and industry spend.
    • In-depth analysis of your reportable and non-reportable data
    • Caters to reports in all reportable States

Data Validation for Error-free Reporting

Our system has 450+ built-in data validation rules to compile your reports accurately.

  • Remediates issues in time
  • Helps track risky transactions
  • No last-minute headaches in March
  • Gives confidence regarding your reports

Remediation has never been simpler

Load your data and check for outliers and anomalies before CMS

  • Built-in AI
  • World-class customer service with 9.7 NPS score and 100% renewal rate
  • Edit multiple transactions at the click of a button

3x more value than other solutions

If you are underwhelmed by your current Transparency Reporting Solution, consider us for a price competitive quotation for 3x more value.

US Federal Transparency Reporting Requirements

Key Dates

Report Due Date: March 31


The Patient Protection and Affordability Care Act, Department of Health and Human Services, Centers for Medicare and Medicaid Services 42 CFR Parts 402 and 403

Who Must Report?

Pharmaceutical and medical device manufacturers

Pharmaceutical Companies and Medical Device Companies.

Latest updated: 27  August 2022

Covered Recipients
  • Physicians
  • Physician assistants
  • Nurse practitioners
  • Clinical nurse specialists
  • Certified registered nurse anaesthetists
  • Certified nurse midwives
Who Must Report?
  • Pharmaceutical and medical device manufacturers
  • Companies with less than 10% revenue generated through “covered products” do not have to report all Transfers of Value, only those related to one or more covered drugs, devices, biologicals or medical supplies.
  • Entities contributing to the manufacturing process of a covered product but have no business presence in the United States.
  • Entities manufacturing raw materials or components only, which are not covered products. However, entities that are under common ownership with an applicable manufacturer and assist such manufacturer with the production, preparation, propagation, compounding, conversion, marketing, promotion, sale, or distribution of a covered drug, device, biological, or medical supply, do not qualify for this exemption.
  • Hospitals, hospital-based pharmacies, and laboratories that manufacture a covered product solely for internal use themselves or by an entity’s own patients.
  • Wholesalers or distributors who don’t hold the title of a covered product will not be subject to the reporting requirements, except for those under common ownership with an applicable manufacturer and assist or support with respect to a covered drug, device, biological, or medical supply.
  • The applicable manufacturer does not manufacture a covered drug, device, biological, or medical supply, with the exception of manufacturing the covered product for another entity under a written agreement, does not hold the FDA approval, licensure, or clearance for the product, and is not involved in the sale, marketing or distribution of the product. In this case, the manufacturer is only required to report payments or other transfers of value related to the covered product.
What is reported?
  • All payments, gifts, and other transfers of value made to U.S. physicians and teaching hospitals (with specified exclusions):
  • Acquisitions
  • Charitable contribution
  • Compensation for non-consulting services
  • Consulting fee
  • Current or prospective ownership or investment interest
  • Debt forgiveness
  • Education
  • Entertainment
  • Food and beverage
  • Gift
  • Grant
  • Honoraria
  • Long-term medical device supply or loan
  • Research
  • Royalty or license
  • Space rental or facility fees
  • Travel and lodging
  • For 2022, the Open Payment regulations require that companies report individual transfers greater than $11.64.
  • For 2022, if the aggregate amount for a single HCP or HCO is greater than or equal to $116.35, all transfers of value, regardless of amount, are reportable.
  • Data points to be disclosed:
  • Name and address of the recipient
  • National Provider Identifier (NPI) and state license of the recipient
  • Amount of the transfer of value
  • Date of the transfer of value
  • Form of payment (cash/in-kind items, etc.)
  • Nature of payment
  • Marketed name of the drug/device
  • Any other requested information
How to Report
  • Annual reports must be submitted at the Centres for Medicare and Medicaid Services at